Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Melanoma HELP
Based on 34,116 articles published since 2008
|||| 19 

These are the 34116 published articles about Melanoma that originated from Worldwide during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
176 Editorial Is chemotherapy still an option in the treatment of melanoma? 2015

Carlino, M S / Long, G V. ·Melanoma Institute Australia, Sydney The Sydney Medical School, The University of Sydney, Sydney Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney. · Melanoma Institute Australia, Sydney The Sydney Medical School, The University of Sydney, Sydney The Mater Hospital, North Sydney, Australia georgina.long@sydney.edu.au. ·Ann Oncol · Pubmed #26374287.

ABSTRACT: -- No abstract --

177 Editorial Skin self-examination for concerning pigmented lesions appears to be consistent with dermatologist examination. 2015

Barton, Mary Kay. · ·CA Cancer J Clin · Pubmed #26352483.

ABSTRACT: -- No abstract --

178 Editorial Peril in perishing pericytes. 2015

Péault, Bruno. ·MRC Centre for Regenerative Medicine, Edinburgh, UK Dept of Orthopaedic Surgery and Broad Stem Cell Center, University of California, Los Angeles, USA bpeault@mednet.ucla.edu. ·J Natl Cancer Inst · Pubmed #26296363.

ABSTRACT: -- No abstract --

179 Editorial Counterpoint: The "dysplastic" nevus: What I do and do not believe. 2015

Cockerell, Clay J. ·Department of Dermatology, University of Texas Southwestern Medical Center, and Cockerell Dermatopathology, Dallas, Texas. Electronic address: ccockerell@dermpath.com. ·J Am Acad Dermatol · Pubmed #26282799.

ABSTRACT: -- No abstract --

180 Editorial Point: What's in a name? 2015

Elder, David E. ·Anatomic Pathology, University of Pennsylvania Perelman School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. ·J Am Acad Dermatol · Pubmed #26282798.

ABSTRACT: -- No abstract --

181 Editorial [The frontage and the other headlines]. 2015

Vignot, Stéphane / Magné, Nicolas. ·Hôpital Louis-Pasteur, service d'oncologie et de hématologie, 6, rue Claude-Bernard, 28630 Chartres Le Coudray, France. Electronic address: svignot@ch-chartres.fr. · Institut de cancérologie Lucien-Neuwirth, département de radiothérapie, 108 bis, avenue Albert-Raimond, BP 60008, 42271 Saint-Priest-en-Jarez cedex, France. ·Bull Cancer · Pubmed #26281942.

ABSTRACT: -- No abstract --

182 Editorial Turning the page. 2015

Bosenberg, Marcus. · ·Pigment Cell Melanoma Res · Pubmed #26277691.

ABSTRACT: -- No abstract --

183 Editorial The Forecast Is Bright: Recent Advances in Melanoma Treatment. 2015

Rivers, Jason K. · ·J Cutan Med Surg · Pubmed #26271962.

ABSTRACT: -- No abstract --

184 Editorial Broad Applicability of Nivolumab in Melanoma Regardless of BRAF Mutation Status. 2015

Gangadhar, Tara C / Schuchter, Lynn M. ·Division of Hematology-Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia. ·JAMA Oncol · Pubmed #26181246.

ABSTRACT: -- No abstract --

185 Editorial Targeted Therapies in Melanoma: Translational Research at Its Finest. 2015

Ho, Allen W / Tsao, Hensin. ·Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA; Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, USA. Electronic address: htsao@partners.org. ·J Invest Dermatol · Pubmed #26174532.

ABSTRACT: -- No abstract --

186 Editorial The conquest of melanoma by immunotherapy. 2015

Lejeune, Ferdy J. ·Department of Oncology, University of Lausanne, Lausanne, Switzerland. ·Melanoma Res · Pubmed #26173006.

ABSTRACT: -- No abstract --

187 Editorial Dietary Advice for Melanoma: Not Ready for Prime Time. 2015

Berwick, Marianne. ·University of New Mexico, Albuquerque, NM mberwick@salud.unm.edu. ·J Clin Oncol · Pubmed #26124491.

ABSTRACT: -- No abstract --

188 Editorial Melanoma research gathers momentum. 2015

Anonymous6040833. · ·Lancet · Pubmed #26088624.

ABSTRACT: -- No abstract --

189 Editorial Can we use rare-earth nanocrystals to target glycans for the visualization of melanoma? 2015

Bilyy, Rostyslav / Podhorodecki, Artur. ·Danylo Halytsky Lviv National Medical University, Pekarska Street 69, Lviv 79010, Ukraine. · Institute of Cell Biology NAS of Ukraine, Drahomanov Street 14/16, Lviv 79005, Ukraine. · Department of Experimental Physics, Wroclaw University of Technology, Wybrzeze Wyspianskiego 27, 50-370 Wroclaw, Poland. ·Nanomedicine (Lond) · Pubmed #26084444.

ABSTRACT: -- No abstract --

190 Editorial Successes and setbacks of early investigational drugs for melanoma. 2015

Orloff, Marlana / Valsecchi, Matias E / Sato, Takami. ·Thomas Jefferson University, Department of Medical Oncology , 1015 Walnut Street, Philadelphia, PA 19107 , USA +1 215 955 1195 ; +1 215 923 0797 ; Marlana.Orloff@jefferson.edu. ·Expert Opin Investig Drugs · Pubmed #26068553.

ABSTRACT: Treatment of advanced and metastatic melanoma is a rapidly changing field. Over the past 10 years, there have been six new drugs approved by the FDA for the treatment of metastatic melanoma. These approved drugs include a number of immune checkpoint inhibitors and MAPK-pathway-targeted therapies. The discovery of such agents as ipilimumab, pembrolizumab, nivolumab, vemurafenib, trametininb and dabrafenib have revolutionized the way in which melanoma in managed. While these agents have succeeded in both early and later phase clinical trials, a large number of investigational therapies have not yet been developed or researched past Phase I clinical studies. Furthermore, there are dozens of potential agents in Phase I and Phase II clinical development that appear promising and are currently being explored. The field currently aims to determine the optimal sequence and combination of these therapies to best overcome such setbacks as toxicity and resistance and build upon the successes previously seen.

191 Editorial Adoptive transfer of tumor-infiltrating lymphocytes for melanoma: new players, old game. 2015

Ben-Ami, Eytan / Schachter, Jacob. ·Ella Lemelbaum Institute for Melanoma, Division of Oncology, Sheba Medical Center, Tel Hashomer, Israel. ·Immunotherapy · Pubmed #26065473.

ABSTRACT: -- No abstract --

192 Editorial Identification of melanoma initiating cells: does CD271 have a future? 2015

Ballotti, Robert. · ·Future Oncol · Pubmed #26043212.

ABSTRACT: -- No abstract --

193 Editorial Identification, clinical significance, and management of very small melanoma metastases in sentinel lymph nodes. 2015

Cochran, Alistair J. ·Departments of Pathology and Laboratory Medicine and Surgery, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA, acochran@mednet.ucla.edu. ·Ann Surg Oncol · Pubmed #26014157.

ABSTRACT: -- No abstract --

194 Editorial Uncertainties in the management of melanoma nodal metastasis. 2015

Zoras, O / Lasithiotakis, K / Balch, C M. ·Department of Surgical Oncology, University Hospital of Crete, Voutes, 71100, Greece. Electronic address: ozoras@med.uoc.gr. · Department of General Surgery, York Teaching Hospital NHS Foundation Trust, The York Hospital Wigginton Road, York, North Yorkshire, YO31 8HE, UK. Electronic address: kwstaslasith@yahoo.gr. · Division of Surgical Oncology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Mail Code 8548, Dallas, TX, 75390-8548, USA. Electronic address: charles.balch@utsouthwestern.edu. ·Eur J Surg Oncol · Pubmed #25980747.

ABSTRACT: -- No abstract --

195 Editorial Implications of the MSLT-1 for sentinel lymph node biopsy in cutaneous head and neck melanoma. 2015

de Bree, E / de Bree, R. ·Melanoma and Sarcoma Unit, Department of Surgical Oncology, Medical School of Crete University Hospital, Heraklion, Greece. · Department of Head and Neck Surgical Oncology, UMC Utrecht Cancer Center, Utrecht, The Netherlands(1); Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: R.deBree@umcutrecht.nl. ·Oral Oncol · Pubmed #25936652.

ABSTRACT: -- No abstract --

196 Editorial Preface. 2015

Makowski, Gregory S. · ·Adv Clin Chem · Pubmed #25934365.

ABSTRACT: -- No abstract --

197 Editorial Tumor-Immune interactions: implications for cancer therapy. 2015

Tham, Muly / Abastado, Jean-Pierre. ·a Singapore Immunology Network ; Singapore. ·Cell Cycle · Pubmed #25894850.

ABSTRACT: -- No abstract --

198 Editorial Decreased Survival Rates of Older-Aged Patients with Melanoma: Biological Differences or Undertreatment? 2015

Balch, Charles M. ·University of Texas Southwestern Medical Center, Dallas, TX, USA, Charles.balch@utsouthwestern.edu. ·Ann Surg Oncol · Pubmed #25840561.

ABSTRACT: -- No abstract --

199 Editorial Sentinel node biopsy in cutaneous melanoma: time for consensus to better inform patient choice. 2015

McGregor, J M / Sasieni, P. ·Blizard Institute, Barts and the London school of Medicine and Dentistry, London, U.K. jane.mcgregor@btinternet.com. ·Br J Dermatol · Pubmed #25776233.

ABSTRACT: -- No abstract --

200 Editorial The Recognition Process in Dermoscopy: Analytic Approach vs Heuristic Approach. 2015

Scope, Alon / Braun, Ralph P. ·Department of Dermatology, Sheba Medical Center, Ramat Gan and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Dermatology, University Hospital Zürich, Switzerland. ·JAMA Dermatol · Pubmed #25715053.

ABSTRACT: -- No abstract --

Back · Next